Kearns Evan's Form 4 filing
Cogent Biosciences, Inc. (COGT) · filed Dec 30, 2025
- Accession no.
- 0001193125-25-337052
- Filed
- Dec 30, 2025
- Trade date
- Dec 26, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $2.52M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kearns EvanCIK 0001745285 | Officer (Chief Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 26, 2025 | Common Stock | SSaleDisposed | −65,000 | $38.70 | −$2,515,500 | 109,398 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.